Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Plasmodium falciparum food vacuole (FV) is a specialized lysosome-like acidic compartment within the malaria parasite that serves as the primary site for hemoglobin digestion during the parasite's intra-erythrocytic life cycle. This organelle is formed through endocytosis from the parasite plasma membrane via a cytoskeletal ring structure called the cytostome, and it contains multiple proteolytic enzymes including falcipains and plasmepsins that break down host cell hemoglobin to provide essential amino acids and other nutrients for parasite growth and reproduction. The food vacuole has emerged as a major therapeutic target for antimalarial drugs because blocking its function directly prevents parasite survival by cutting off nutrient acquisition and metabolic pathways. Chloroquine, one of the most important antimalarial drugs, acts by accumulating in the food vacuole and inhibiting the crystallization of free heme into hemozoin, a toxic byproduct that must be safely sequestered. However, widespread drug resistance has developed through mutations in key food vacuole membrane proteins such as the chloroquine resistance transporter (PfCRT) and the multidrug resistance protein 1 (PfMDR1), highlighting the need for new therapeutic strategies targeting this compartment and its protein components.
Inhibition of hemoglobin degradation: Compounds targeting food vacuole enzymes (falcipains and plasmepsins) disrupt hemoglobin digestion, preventing nutrient acquisition and parasite survival. Prevention of hemozoin biocrystallization: Chloroquine and related drugs bind to free heme or cap heme polymers, preventing the crystallization process essential for parasite survival. Disruption of nutrient homeostasis: Blocking food vacuole function affects nutrient acquisition and metabolic activities, leading to parasite cell death. Interference with protein trafficking: Inhibitors like Dynasore disrupt dynamin-mediated vesicle formation and protein trafficking to the food vacuole membrane.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium falciparum food vacuole (FV).